RxDoctor Payments Data

Stephen Harris, PA

Physician Assistant · Philippi, WVNPI 1821195637

Payments from drug & device makers

$2,251in general payments, 2019–2025

Across 122 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$455
  • AstraZeneca$344
  • AbbVie$286
  • Pfizer$273
  • Bayer$158
  • Exact Sciences$140
  • plus $596 from 15 others

What the payments were for

  • Food & beverage$2,251100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,251 in reported general payments places this provider in the 85th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Medicare billing

Part B allowed, 2024
$2,331
Medicare patients
31
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide85$92,382
JardianceEmpagliflozin84$72,972
FarxigaDapagliflozin Propanediol44$39,318
TrulicityDulaglutide27$29,447
EliquisApixaban27$27,707
TradjentaLinagliptin38$27,042
Tresiba Flextouch U-100Insulin Degludec21$18,375
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$17,133
VraylarCariprazine Hcl13$16,856
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$15,074
Breo ElliptaFluticasone/Vilanterol33$13,117
JanuviaSitagliptin Phosphate17$11,735
Lantus SolostarInsulin Glargine,hum.Rec.Anlog56$8,588
Repatha SyringeEvolocumab12$6,628
BrilintaTicagrelor12$6,439

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$59$100,014122 claims
Novo NordiskOzempic$455$92,38285 claims
AstraZenecaFarxiga, Brilinta$344$45,75756 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$14$35,87371 claims
Lilly USA, LLCTrulicity$95$29,44727 claims
PfizerEliquis$273$27,70727 claims
AbbVieVraylar$286$16,85613 claims
MerckJanuvia$15$11,73517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Philippi

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →